Inflection Point In Segment Earnings Expected In Q1 For FMC
Analyst Michael J Sison of KeyBanc Capital Markets maintains his "buy" rating on FMC Corporation (NYSE: FMC). The target price for FMC is set to $60.
FMC has reported its Q4 results ahead of the expectations, driven by the strong performance of its Agricultural Products and Specialty Chemicals segments. “While the Industrial Chemicals segment results remain pressured, we anticipate 2010 will prove to be an inflection point in segment earnings,” the analyst says.
According to KeyBanc Capital Markets, FMC's 2010 EPS guidance range of $4.35-$4.75 is healthy and achievable, with some potential upside. The analyst expects an inflection in FMC’s sales during Q1.







